Department of Pathology, Faculty of Medicine, Menoufia University, Shibin Al koom, Egypt.
Department of Clinical Oncology, Faculty of Medicine, Menoufia University, Shibin Al koom, Egypt.
J Immunoassay Immunochem. 2024 Jul 3;45(4):342-361. doi: 10.1080/15321819.2024.2358879. Epub 2024 May 30.
Now, targeted therapy and immunotherapy are promoted. tumour -Associated Macrophages (TAMs) are an essential component of immune-response in breast cancer(BC) with prognostic controversy. Additionally, their recruiting factors are still obscure. Purpose:This study aimed to evaluate the prognostic significance of CD163 and CD47 in BC of No Special Type (BC-NST) and to explore their suggested role in recruiting TAMs.
This immunohistochemical study was conducted on 91 archival specimens of breast cases. Immunoreactivity scores were correlated with TAMs density, clinicopathological data, and survival.
Revealed the highest CD163 expression was detected in the pure DCIS group ( = 0.016), while the highest CD47 expression and high TAMs density were reported in the invasive group ( = 0.008, and = 0.002 respectively) followed by the DCIS group. In IC-NSTs the CD163 and CD47 scores were associated with poor prognostic parameters like(high grade, advanced stage, distant metastasis, ER negativity,Ki67 index, post-surgical chemotherapy, poor NPI group, high mitotic count, dense infiltration of TAMs, shorter OS). Also, CD47 was associated with the dens infiltration of TAMs in DCIS ( = 0.001). There was a significant correlation between tumour cell expression of CD163 and CD47 in IC-NSTs and DCIS ( = 0.002 and = 0.009 respectively).
High CD163 and CD47 expressions in both DCIS andIBC are intimately associated, significantly associated with poor prognosis and are important provoking factors of TAMs.
现在,靶向治疗和免疫疗法得到了推广。肿瘤相关巨噬细胞(TAMs)是乳腺癌(BC)免疫反应的重要组成部分,但它们的预后存在争议。此外,它们的募集因子仍不清楚。目的:本研究旨在评估 CD163 和 CD47 在非特殊型乳腺癌(BC-NST)中的预后意义,并探讨它们在募集 TAMs 中的作用。
本免疫组织化学研究对 91 例乳腺癌存档标本进行了检测。免疫反应评分与 TAMs 密度、临床病理数据和生存相关。
结果显示,纯 DCIS 组的 CD163 表达最高(=0.016),而 CD47 表达和高 TAMs 密度最高的是浸润组(=0.008 和=0.002),其次是 DCIS 组。在 IC-NST 中,CD163 和 CD47 评分与不良预后参数相关,如(高级别、晚期、远处转移、ER 阴性、Ki67 指数、术后化疗、NPI 差、高有丝分裂计数、TAMs 密集浸润、OS 较短)。此外,CD47 与 DCIS 中 TAMs 的密集浸润相关(=0.001)。在 IC-NST 和 DCIS 中,肿瘤细胞表达 CD163 和 CD47 之间存在显著相关性(=0.002 和=0.009)。
DCIS 和 IBC 中高 CD163 和 CD47 表达密切相关,与不良预后显著相关,是 TAMs 的重要诱导因素。